ONDANSETRON Sandoz conc perf 8 mg/4ml 5 amp 4 ml
7680672150024
CH-67215
A04AA01
01.09.0.
Reimbursement limitations:
EMETCHEMOTHE
Chimiothérapie fortement émétogène.
1 / 2
google
Details
- Product number
- 6721502
- CPT
- -
- Packaging group
- 5x4
- Unit
- ml
- Composition
- ondansetronum 8 mg ut ondansetroni hydrochloridum dihydricum, acidum citricum monohydricum, natrii citras dihydricus, natrii chloridum, aqua ad iniectabile q.s. ad solutionem pro 4 ml corresp. natrium 3.6 mg/ml.
Articles (1)
Ondansetron Sandoz 8 mg/4 ml, Infusionskonzentrat/ Injektionslösung
Injektionslösung
5x4
Official Swissmedic V2 data
Additional information from the official database
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
8.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | WIZUS |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
3.6 MGML | Substance | Wirkstoff (Principe actif) |
Reimbursement information
Public price
CHF 79.00
Specialties list
Yes
Generic
Yes
Reimbursement limitation
SL addition date:
01/04/2019
Authorization holder
Sandoz Pharmaceuticals AG
6343 Risch
Authorization information
- Swissmedic authorization number
- 67215
- Drug name
- Ondansetron Sandoz, Infusionskonzentrat/ Injektionslösung
- Galenic form
- LSPA
- ATC Code
- A04AA01
- Authorization status
- Z
- Authorization category
- Category C
- Dispensation category
- B
- First authorization
- 27/09/2018
- Authorization expiration date
- 31/12/9999
- IT number
- 01.09.0.
- Domain
- Human medicine
Packaging details
- Description (FR)
- ONDANSETRON Sandoz conc perf 8 mg/4ml 5 amp 4 ml
- Description (DE)
- ONDANSETRON Sandoz Inf Konz 8 mg/4ml 5 Amp 4 ml
- Market launch
- 27/09/2018
- Narcotic (BTM)
- No